Patents Assigned to ALPHAPTOSE GMBH
  • ORAL DOSAGE FORM COMPRISING TRI-SUBSTITUTED GLYCEROL COMPOUNDS
    Publication number: 20170157150
    Abstract: The present invention relates to pharmaceutical solid dosage forms for oral administration comprising a tri-substituted glycerol compound or a pharmaceutically acceptable salt thereof. The invention also relates to a corresponding method for preparing such dosage forms as well as to their use as medicaments for the treatment of cancer and immune diseases.
    Type: Application
    Filed: February 22, 2017
    Publication date: June 8, 2017
    Applicant: Alphaptose GmbH
    Inventors: Wolfgang Richter, Lutz Weber
  • Oral Dosage Form Comprising Tri-Substituted Glycerol Compounds
    Publication number: 20110110984
    Abstract: The present invention relates to pharmaceutical solid dosage forms for oral administration comprising a tri-substituted glycerol compound or a pharmaceutically acceptable salt thereof. The invention also relates to a corresponding method for preparing such dosage forms as well as to their use as medicaments for the treatment of cancer and immune diseases.
    Type: Application
    Filed: November 9, 2007
    Publication date: May 12, 2011
    Applicant: Alphaptose GmBH
    Inventors: Wolfgang Richter, Lutz Weber
  • Topical Dosage Form Comprising Tri-Substituted Glycerol Compounds
    Publication number: 20100179226
    Abstract: The present invention relates to pharmaceutical dosage forms for topical administration comprising a tri-substituted glycerol compound or a pharmaceutically acceptable salt thereof. The invention also relates to a corresponding method for preparing such dosage forms as well as to their use as medicaments for the treatment of cancer and immune diseases.
    Type: Application
    Filed: November 9, 2007
    Publication date: July 15, 2010
    Applicant: ALPHAPTOSE GMBH
    Inventors: Julia Diederichs, Wolfgang Richter, Lutz Weber
  • Use of Tri-Substituted Glycerol Compounds for the Treatment of Hematological Malignancies
    Publication number: 20100136029
    Abstract: The present invention relates to the use of a tri-substituted glycerol compound for the manufacture of a medicament for the treatment of hematological malignancies. The invention also refers to a kit-of-parts comprising such a medicament. Finally, the invention also relates to a corresponding method for the treatment of such conditions as well as to an in vitro method for determining the susceptibility of such malignant cells to a medicament as defined in the invention.
    Type: Application
    Filed: November 9, 2007
    Publication date: June 3, 2010
    Applicants: UNIVERSITATSKLINIKUM HAMBURG-EPPENDORF, ALPHAPTOSE GMBH
    Inventors: Axel Rolf Zander, Francis Ayuk Ayuketang, Wolfgang Richter, Lutz Weber
  • Use of Tri-Substituted Glycerol Compounds for the Treatment of Radiation Injuries
    Publication number: 20100130449
    Abstract: The present invention relates to the use of a tri-substituted glycerol compound or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the prevention and/or treatment of radiation injuries. Furthermore, the invention relates to in vitro corresponding methods for preventing or treating of radiation damage or injury in one or more cells comprising contacting said cells with a medicament as defined in the invention.
    Type: Application
    Filed: November 9, 2007
    Publication date: May 27, 2010
    Applicant: ALPHAPTOSE GMBH
    Inventors: Wolfgang Richter, Lutz Weber
  • Methods and Compositions for Detecting Receptor Ligand Mimetics
    Publication number: 20100111930
    Abstract: A method to determine the utility of small molecules as functional replacements (mimetics) for protein receptor ligands is described. The method uses cellular biological assays on a systematic array of compounds, comprising known protein receptor ligands and other biologically active molecules to determine if a proposed small molecule is a functional equivalent of a receptor ligand, having therapeutic utility as a pharmaceutically relevant and useful agent either alone or in combination with other molecules.
    Type: Application
    Filed: November 9, 2007
    Publication date: May 6, 2010
    Applicant: ALPHAPTOSE GMBH
    Inventors: Vladimir Khazak, Lutz Weber